VODELPA
DEAD

Serial Number

97600688

Owner

Novartis AG

Attorney

Maury M. Tepper, III

Filing Date

Sep 21, 2022

Add to watchlist:

No watchlists yet
View on USPTO

VODELPA Trademark

Serial Number: 97600688

VODELPA is a trademark filed by Novartis AG on September 21, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Novartis AG (12 trademarks)

CH-4002 Basel

Entity Type: 03

Trademark Details

Filing Date

September 21, 2022

Registration Date

Not Registered

Published for Opposition

December 27, 2022

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Mar 23, 2026 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Mar 23, 2026 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 19, 2025 EXRA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 18, 2025 CHAN
SOU EXTENSION 5 GRANTED
Nov 18, 2025 EX5G
SOU EXTENSION 5 FILED
Nov 18, 2025 EXT5
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 18, 2025 AITU
TEAS POST PUBLICATION AMENDMENT RECEIVED
Aug 26, 2025 EPPA
SOU TEAS EXTENSION RECEIVED
Aug 17, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 12, 2025 EXRA
SOU EXTENSION 4 GRANTED
Feb 12, 2025 EX4G
SOU EXTENSION 4 FILED
Feb 11, 2025 EXT4
SOU TEAS EXTENSION RECEIVED
Feb 11, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 15, 2024 EXRA
SOU EXTENSION 3 GRANTED
Aug 15, 2024 EX3G
SOU EXTENSION 3 FILED
Aug 15, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Aug 15, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 21, 2024 EXRA
SOU EXTENSION 2 GRANTED
Feb 20, 2024 EX2G
SOU EXTENSION 2 FILED
Feb 20, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Feb 20, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 8, 2023 EXRA
SOU EXTENSION 1 GRANTED
Aug 4, 2023 EX1G
SOU EXTENSION 1 FILED
Aug 4, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Aug 4, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 21, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 27, 2022 NPUB
PUBLISHED FOR OPPOSITION
Dec 27, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 7, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 18, 2022 CNSA
ASSIGNED TO EXAMINER
Nov 17, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 6, 2022 NWOS
NEW APPLICATION ENTERED
Sep 24, 2022 NWAP